Italian scientists say their vaccine neutralises virus, human trials soon

Rome:

Italian scientists claim to have developed a vaccine candidate that could neutralise coronavirus within human cells.

According to findings from the tests conducted at Spallanzani Hospital in Rome, the vaccine generated antibodies in mice that work on human cells. Takis Biotech is developing the coronavirus vaccine candidate. Italian news agency ANSA quoted Takis Biotech CEO Luigi Aurisicchio as saing: “This is the most advanced stage of testing of a candidate vaccine created in Italy. Human tests are expected after this summer.”

All of the vaccine candidates being developed are based on the genetic material of DNA protein ‘spike’, the molecular tip used by the coronavirus to enter human cells. The vaccine uses a technique called electroporation to help break into the cells and induce the immune system. This mechanism is expected to boost the vaccine’s effectiveness in producing antibodies against ‘spike’ protein in lung cells. AGENCIES